Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Barriers to accessing public cancer genomic data.

Learned K, Durbin A, Currie R, Kephart ET, Beale HC, Sanders LM, Pfeil J, Goldstein TC, Salama SR, Haussler D, Vaske OM, Bjork IM.

Sci Data. 2019 Jun 20;6(1):98. doi: 10.1038/s41597-019-0096-4. No abstract available.

PMID:
31222016
2.

Prevalence of intellectual and developmental disabilities among first generation adult newcomers, and the health and health service use of this group: A retrospective cohort study.

Durbin A, Jung JKH, Chung H, Lin E, Balogh R, Lunsky Y.

PLoS One. 2019 Jun 20;14(6):e0215804. doi: 10.1371/journal.pone.0215804. eCollection 2019.

3.

Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response.

Krubiner CB, Faden RR, Karron RA, Little MO, Lyerly AD, Abramson JS, Beigi RH, Cravioto AR, Durbin AP, Gellin BG, Gupta SB, Kaslow DC, Kochhar S, Luna F, Saenz C, Sheffield JS, Tindana PO; PREVENT Working Group.

Vaccine. 2019 May 3. pii: S0264-410X(19)30045-3. doi: 10.1016/j.vaccine.2019.01.011. [Epub ahead of print] Review.

4.

Repeat Emergency Department Visits for Individuals With Intellectual and Developmental Disabilities and Psychiatric Disorders.

Durbin A, Balogh R, Lin E, Wilton AS, Selick A, Dobranowski KM, Lunsky Y.

Am J Intellect Dev Disabil. 2019 May;124(3):206-219. doi: 10.1352/1944-7558-124.3.206.

PMID:
31026200
5.

Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines.

Swanstrom JA, Nivarthi UK, Patel B, Delacruz MJ, Yount B, Widman DG, Durbin AP, Whitehead SS, De Silva AM, Baric RS.

J Infect Dis. 2019 Jun 19;220(2):219-227. doi: 10.1093/infdis/jiz109.

6.

Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model.

Nivarthi UK, Tu HA, Delacruz MJ, Swanstrom J, Patel B, Durbin AP, Whitehead SS, Pierce KK, Kirkpatrick BD, Baric RS, Nguyen N, Emerling DE, de Silva AM, Diehl SA.

EBioMedicine. 2019 Mar;41:465-478. doi: 10.1016/j.ebiom.2019.02.060. Epub 2019 Mar 8.

7.

Are resilience and perceived stress related to social support and housing stability among homeless adults with mental illness?

Durbin A, Nisenbaum R, Kopp B, O'Campo P, Hwang SW, Stergiopoulos V.

Health Soc Care Community. 2019 Jul;27(4):1053-1062. doi: 10.1111/hsc.12722. Epub 2019 Feb 7.

PMID:
30734374
8.

Borderline Intellectual Functioning and Lifetime Duration of Homelessness among Homeless Adults with Mental Illness.

Durbin A, Lunsky Y, Wang R, Nisenbaum R, Hwang SW, O'Campo P, Stergiopoulos V.

Healthc Policy. 2018 Nov;14(2):40-46. doi: 10.12927/hcpol.2018.25687.

PMID:
30710440
9.

What is the prospect of a safe and effective dengue vaccine for travelers?

Durbin AP, Gubler DJ.

J Travel Med. 2019 Jan 18. doi: 10.1093/jtm/tay153. [Epub ahead of print] No abstract available.

PMID:
30657935
10.

Cutting Edge: Transcriptional Profiling Reveals Multifunctional and Cytotoxic Antiviral Responses of Zika Virus-Specific CD8+ T Cells.

Grifoni A, Costa-Ramos P, Pham J, Tian Y, Rosales SL, Seumois G, Sidney J, de Silva AD, Premkumar L, Collins MH, Stone M, Norris PJ, Romero CME, Durbin A, Ricciardi MJ, Ledgerwood JE, de Silva AM, Busch M, Peters B, Vijayanand P, Harris E, Falconar AK, Kallas E, Weiskopf D, Sette A.

J Immunol. 2018 Dec 15;201(12):3487-3491. doi: 10.4049/jimmunol.1801090. Epub 2018 Nov 9.

11.

Genetic Variation between Dengue Virus Type 4 Strains Impacts Human Antibody Binding and Neutralization.

Gallichotte EN, Baric TJ, Nivarthi U, Delacruz MJ, Graham R, Widman DG, Yount BL, Durbin AP, Whitehead SS, de Silva AM, Baric RS.

Cell Rep. 2018 Oct 30;25(5):1214-1224. doi: 10.1016/j.celrep.2018.10.006.

12.

Whole genome sequencing, variant analysis, phylogenetics, and deep sequencing of Zika virus strains.

Shrivastava S, Puri V, Dilley KA, Ngouajio E, Shifflett J, Oldfield LM, Fedorova NB, Hu L, Williams T, Durbin A, Amedeo P, Rashid S, Shabman RS, Pickett BE.

Sci Rep. 2018 Oct 26;8(1):15843. doi: 10.1038/s41598-018-34147-7.

13.

Viridot: An automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virus.

Katzelnick LC, Coello Escoto A, McElvany BD, Chávez C, Salje H, Luo W, Rodriguez-Barraquer I, Jarman R, Durbin AP, Diehl SA, Smith DJ, Whitehead SS, Cummings DAT.

PLoS Negl Trop Dis. 2018 Oct 24;12(10):e0006862. doi: 10.1371/journal.pntd.0006862. eCollection 2018 Oct.

14.

Impact of Dengue Virus Serotype 2 Strain Diversity on Serological Immune Responses to Dengue.

Keasey SL, Smith JL, Fernandez S, Durbin AP, Zhao BM, Ulrich RG.

ACS Infect Dis. 2018 Dec 14;4(12):1705-1717. doi: 10.1021/acsinfecdis.8b00185. Epub 2018 Nov 5.

PMID:
30347144
15.

Development of standard clinical endpoints for use in dengue interventional trials.

Tomashek KM, Wills B, See Lum LC, Thomas L, Durbin A, Leo YS, de Bosch N, Rojas E, Hendrickx K, Erpicum M, Agulto L, Jaenisch T, Tissera H, Suntarattiwong P, Collers BA, Wallace D, Schmidt AC, Precioso A, Narvaez F, Thomas SJ, Edelman R, Siqueira JB, Cassetti MC, Dempsey W, Gubler DJ.

PLoS Negl Trop Dis. 2018 Oct 4;12(10):e0006497. doi: 10.1371/journal.pntd.0006497. eCollection 2018 Oct.

16.

Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry.

Durbin AD, Zimmerman MW, Dharia NV, Abraham BJ, Iniguez AB, Weichert-Leahey N, He S, Krill-Burger JM, Root DE, Vazquez F, Tsherniak A, Hahn WC, Golub TR, Young RA, Look AT, Stegmaier K.

Nat Genet. 2018 Sep;50(9):1240-1246. doi: 10.1038/s41588-018-0191-z. Epub 2018 Aug 20.

17.

The Mental Health of Adults with Developmental Disabilities in Ontario: Lessons from Administrative Health Data.

Lunsky Y, Balogh R, Durbin A, Selick A, Volpe T, Lin E.

Healthc Q. 2018 Apr;21(1):6-9. doi: 10.12927/hcq.2018.25521.

PMID:
30051808
18.

Early Transcriptional Responses After Dengue Vaccination Mirror the Response to Natural Infection and Predict Neutralizing Antibody Titers.

Popper SJ, Strouts FR, Lindow JC, Cheng HK, Montoya M, Balmaseda A, Durbin AP, Whitehead SS, Harris E, Kirkpatrick BD, Relman DA.

J Infect Dis. 2018 Nov 5;218(12):1911-1921. doi: 10.1093/infdis/jiy434.

PMID:
30010906
19.

Emergency Department Use: Common Presenting Issues and Continuity of Care for Individuals With and Without Intellectual and Developmental Disabilities.

Durbin A, Balogh R, Lin E, Wilton AS, Lunsky Y.

J Autism Dev Disord. 2018 Oct;48(10):3542-3550. doi: 10.1007/s10803-018-3615-9.

PMID:
29923146
20.

The Effect of Housing First on Housing Stability for People with Mental Illness and Low Intellectual Functioning.

Durbin A, Lunsky Y, Wang R, Nisenbaum R, Hwang SW, O'Campo P, Stergiopoulos V.

Can J Psychiatry. 2018 Jan 1:706743718782940. doi: 10.1177/0706743718782940. [Epub ahead of print]

21.

Human induced pluripotent stem cell-derived glial cells and neural progenitors display divergent responses to Zika and dengue infections.

Muffat J, Li Y, Omer A, Durbin A, Bosch I, Bakiasi G, Richards E, Meyer A, Gehrke L, Jaenisch R.

Proc Natl Acad Sci U S A. 2018 Jul 3;115(27):7117-7122. doi: 10.1073/pnas.1719266115. Epub 2018 Jun 18.

22.

Sequences of Zika Virus Genomes from a Pediatric Cohort in Nicaragua.

Oldfield LM, Fedorova N, Puri V, Shrivastava S, Amedeo P, Durbin A, Rocchi I, Williams T, Shabman RS, Tan GS, Balmaseda A, Kuan G, Saborio S, Gordon A, Harris E, Pickett BE.

Genome Announc. 2018 Jun 14;6(24). pii: e00498-18. doi: 10.1128/genomeA.00498-18.

23.

Zika vaccines and therapeutics: landscape analysis and challenges ahead.

Wilder-Smith A, Vannice K, Durbin A, Hombach J, Thomas SJ, Thevarjan I, Simmons CP.

BMC Med. 2018 Jun 6;16(1):84. doi: 10.1186/s12916-018-1067-x.

24.

Diffusion-Weighted Imaging Changes in a Child With Posterior Ischemic Optic Neuropathy.

Harrar DB, Solomon J, Shah AS, Vaughn J, Durbin AD, Rivkin MJ.

Pediatr Neurol. 2018 Jul;84:49-52. doi: 10.1016/j.pediatrneurol.2018.03.014. Epub 2018 Apr 4.

PMID:
29859720
25.

Field-deployable viral diagnostics using CRISPR-Cas13.

Myhrvold C, Freije CA, Gootenberg JS, Abudayyeh OO, Metsky HC, Durbin AF, Kellner MJ, Tan AL, Paul LM, Parham LA, Garcia KF, Barnes KG, Chak B, Mondini A, Nogueira ML, Isern S, Michael SF, Lorenzana I, Yozwiak NL, MacInnis BL, Bosch I, Gehrke L, Zhang F, Sabeti PC.

Science. 2018 Apr 27;360(6387):444-448. doi: 10.1126/science.aas8836.

26.

Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines.

Vannice KS, Wilder-Smith A, Barrett ADT, Carrijo K, Cavaleri M, de Silva A, Durbin AP, Endy T, Harris E, Innis BL, Katzelnick LC, Smith PG, Sun W, Thomas SJ, Hombach J.

Vaccine. 2018 Jun 7;36(24):3411-3417. doi: 10.1016/j.vaccine.2018.02.062. Epub 2018 Mar 7.

27.

Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes.

Gallichotte EN, Baric TJ, Yount BL Jr, Widman DG, Durbin A, Whitehead S, Baric RS, de Silva AM.

PLoS Pathog. 2018 Feb 26;14(2):e1006934. doi: 10.1371/journal.ppat.1006934. eCollection 2018 Feb.

28.

Whole-Genome Sequences of Zika Virus FLR Strains after Passage in Vero or C6/36 Cells.

Moser LA, Oldfield LM, Fedorova N, Puri V, Shrivastava S, Amedeo P, Isom R, Hu L, Durbin A, Rocchi I, Williams T, Tan GS, Shabman RS, Bernard KA, Pickett BE.

Genome Announc. 2018 Jan 25;6(4). pii: e01528-17. doi: 10.1128/genomeA.01528-17.

29.

MYC Drives a Subset of High-Risk Pediatric Neuroblastomas and Is Activated through Mechanisms Including Enhancer Hijacking and Focal Enhancer Amplification.

Zimmerman MW, Liu Y, He S, Durbin AD, Abraham BJ, Easton J, Shao Y, Xu B, Zhu S, Zhang X, Li Z, Weichert-Leahey N, Young RA, Zhang J, Look AT.

Cancer Discov. 2018 Mar;8(3):320-335. doi: 10.1158/2159-8290.CD-17-0993. Epub 2017 Dec 28.

30.

Zika Vaccines: Role for Controlled Human Infection.

Durbin AP, Whitehead SS.

J Infect Dis. 2017 Dec 16;216(suppl_10):S971-S975. doi: 10.1093/infdis/jix491. Review.

31.

Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4.

Widman DG, Young E, Nivarthi U, Swanstrom JA, Royal SR, Yount BL, Debbink K, Begley M, Marcet S, Durbin A, de Silva AM, Messer WB, Baric RS.

Sci Rep. 2017 Dec 7;7(1):17169. doi: 10.1038/s41598-017-17355-5.

32.

Mental Health Disorders and Publicly Funded Service Use by HIV Positive Individuals: A Population-Based Cross-Sectional Study in Ontario, Canada.

Durbin A, Brown HK, Antoniou T, Sirotich F, Bansal S, Heifetz M, Roesslein K, Lunsky Y.

AIDS Behav. 2017 Dec;21(12):3457-3463. doi: 10.1007/s10461-017-1949-5.

PMID:
29098454
33.

Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas.

Grifoni A, Angelo MA, Lopez B, O'Rourke PH, Sidney J, Cerpas C, Balmaseda A, Silveira CGT, Maestri A, Costa PR, Durbin AP, Diehl SA, Phillips E, Mallal S, De Silva AD, Nchinda G, Nkenfou C, Collins MH, de Silva AM, Lim MQ, Macary PA, Tatullo F, Solomon T, Satchidanandam V, Desai A, Ravi V, Coloma J, Turtle L, Rivino L, Kallas EG, Peters B, Harris E, Sette A, Weiskopf D.

Front Immunol. 2017 Oct 13;8:1309. doi: 10.3389/fimmu.2017.01309. eCollection 2017.

34.

Rapid changes in serum cytokines and chemokines in response to inactivated influenza vaccination.

Talaat KR, Halsey NA, Cox AB, Coles CL, Durbin AP, Ramakrishnan A, Bream JH.

Influenza Other Respir Viruses. 2018 Mar;12(2):202-210. doi: 10.1111/irv.12509. Epub 2018 Jan 4.

35.

Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans.

Grifoni A, Pham J, Sidney J, O'Rourke PH, Paul S, Peters B, Martini SR, de Silva AD, Ricciardi MJ, Magnani DM, Silveira CGT, Maestri A, Costa PR, de-Oliveira-Pinto LM, de Azeredo EL, Damasco PV, Phillips E, Mallal S, de Silva AM, Collins M, Durbin A, Diehl SA, Cerpas C, Balmaseda A, Kuan G, Coloma J, Harris E, Crowe JE Jr, Stone M, Norris PJ, Busch M, Vivanco-Cid H, Cox J, Graham BS, Ledgerwood JE, Turtle L, Solomon T, Kallas EG, Watkins DI, Weiskopf D, Sette A.

J Virol. 2017 Nov 30;91(24). pii: e01469-17. doi: 10.1128/JVI.01469-17. Print 2017 Dec 15.

36.

Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum.

Bosch I, de Puig H, Hiley M, Carré-Camps M, Perdomo-Celis F, Narváez CF, Salgado DM, Senthoor D, O'Grady M, Phillips E, Durbin A, Fandos D, Miyazaki H, Yen CW, Gélvez-Ramírez M, Warke RV, Ribeiro LS, Teixeira MM, Almeida RP, Muñóz-Medina JE, Ludert JE, Nogueira ML, Colombo TE, Terzian ACB, Bozza PT, Calheiros AS, Vieira YR, Barbosa-Lima G, Vizzoni A, Cerbino-Neto J, Bozza FA, Souza TML, Trugilho MRO, de Filippis AMB, de Sequeira PC, Marques ETA, Magalhaes T, Díaz FJ, Restrepo BN, Marín K, Mattar S, Olson D, Asturias EJ, Lucera M, Singla M, Medigeshi GR, de Bosch N, Tam J, Gómez-Márquez J, Clavet C, Villar L, Hamad-Schifferli K, Gehrke L.

Sci Transl Med. 2017 Sep 27;9(409). pii: eaan1589. doi: 10.1126/scitranslmed.aan1589.

PMID:
28954927
37.

Predictors of emergency department use by adolescents and adults with autism spectrum disorder: a prospective cohort study.

Lunsky Y, Weiss JA, Paquette-Smith M, Durbin A, Tint A, Palucka AM, Bradley E.

BMJ Open. 2017 Jul 18;7(7):e017377. doi: 10.1136/bmjopen-2017-017377.

38.

Dengue vaccines: implications for dengue control.

Robinson ML, Durbin AP.

Curr Opin Infect Dis. 2017 Oct;30(5):449-454. doi: 10.1097/QCO.0000000000000394. Review.

PMID:
28719400
39.

An update on Zika vaccine developments.

Durbin A, Wilder-Smith A.

Expert Rev Vaccines. 2017 Aug;16(8):781-787. doi: 10.1080/14760584.2017.1345309. Review.

PMID:
28633549
40.

The NOTCH1/SNAIL1/MEF2C Pathway Regulates Growth and Self-Renewal in Embryonal Rhabdomyosarcoma.

Ignatius MS, Hayes MN, Lobbardi R, Chen EY, McCarthy KM, Sreenivas P, Motala Z, Durbin AD, Molodtsov A, Reeder S, Jin A, Sindiri S, Beleyea BC, Bhere D, Alexander MS, Shah K, Keller C, Linardic CM, Nielsen PG, Malkin D, Khan J, Langenau DM.

Cell Rep. 2017 Jun 13;19(11):2304-2318. doi: 10.1016/j.celrep.2017.05.061.

41.

How HIV affects health and service use for adults with intellectual and developmental disabilities.

Durbin A, Brown HK, Bansal S, Antoniou T, Jung JKH, Lunsky Y.

J Intellect Disabil Res. 2017 Jul;61(7):682-696. doi: 10.1111/jir.12381.

PMID:
28612475
42.

In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination.

Whitehead SS, Durbin AP, Pierce KK, Elwood D, McElvany BD, Fraser EA, Carmolli MP, Tibery CM, Hynes NA, Jo M, Lovchik JM, Larsson CJ, Doty EA, Dickson DM, Luke CJ, Subbarao K, Diehl SA, Kirkpatrick BD.

PLoS Negl Trop Dis. 2017 May 8;11(5):e0005584. doi: 10.1371/journal.pntd.0005584. eCollection 2017 May.

43.

Antibody Responses to Zika Virus Infections in Environments of Flavivirus Endemicity.

Keasey SL, Pugh CL, Jensen SMR, Smith JL, Hontz RD, Durbin AP, Dudley DM, O'Connor DH, Ulrich RG.

Clin Vaccine Immunol. 2017 Apr 5;24(4). pii: e00036-17. doi: 10.1128/CVI.00036-17. Print 2017 Apr.

44.

Patterns of Cellular Immunity Associated with Experimental Infection with rDEN2Δ30 (Tonga/74) Support Its Suitability as a Human Dengue Virus Challenge Strain.

Grifoni A, Angelo M, Sidney J, Paul S, Peters B, de Silva AD, Phillips E, Mallal S, Diehl SA, Botten J, Boyson J, Kirkpatrick BD, Whitehead SS, Durbin AP, Sette A, Weiskopf D.

J Virol. 2017 Mar 29;91(8). pii: e02133-16. doi: 10.1128/JVI.02133-16. Print 2017 Apr 15.

45.

A Live Attenuated Chimeric West Nile Virus Vaccine, rWN/DEN4Δ30, Is Well Tolerated and Immunogenic in Flavivirus-Naive Older Adult Volunteers.

Pierce KK, Whitehead SS, Kirkpatrick BD, Grier PL, Jarvis A, Kenney H, Carmolli MP, Reynolds C, Tibery CM, Lovchik J, Janiak A, Luke CJ, Durbin AP, Pletnev AG.

J Infect Dis. 2017 Jan 1;215(1):52-55. doi: 10.1093/infdis/jiw501. Epub 2016 Oct 25.

46.

Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.

Nivarthi UK, Kose N, Sapparapu G, Widman D, Gallichotte E, Pfaff JM, Doranz BJ, Weiskopf D, Sette A, Durbin AP, Whitehead SS, Baric R, Crowe JE Jr, de Silva AM.

J Virol. 2017 Feb 14;91(5). pii: e02041-16. doi: 10.1128/JVI.02041-16. Print 2017 Mar 1.

47.

Human CD4+ T Cell Responses to an Attenuated Tetravalent Dengue Vaccine Parallel Those Induced by Natural Infection in Magnitude, HLA Restriction, and Antigen Specificity.

Angelo MA, Grifoni A, O'Rourke PH, Sidney J, Paul S, Peters B, de Silva AD, Phillips E, Mallal S, Diehl SA, Kirkpatrick BD, Whitehead SS, Durbin AP, Sette A, Weiskopf D.

J Virol. 2017 Feb 14;91(5). pii: e02147-16. doi: 10.1128/JVI.02147-16. Print 2017 Mar 1.

48.

Health profiles and associated service use among adults with HIV and intellectual and developmental disabilities.

Lunsky Y, Durbin A, Brown HK, Bansal S, Heifetz M, Antoniou T.

AIDS. 2017 Mar 13;31(5):697-705. doi: 10.1097/QAD.0000000000001361.

PMID:
27922856
49.

Meeting Report: WHO consultation on considerations for regulatory expectations of Zika virus vaccines for use during an emergency.

Vannice KS, Giersing BK, Kaslow DC, Griffiths E, Meyer H, Barrett A, Durbin AP, Wood D, Hombach J.

Vaccine. 2016 Dec 20. pii: S0264-410X(16)30969-0. doi: 10.1016/j.vaccine.2016.10.034. [Epub ahead of print]

PMID:
27916410
50.

Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults.

Talaat KR, Ellis RD, Hurd J, Hentrich A, Gabriel E, Hynes NA, Rausch KM, Zhu D, Muratova O, Herrera R, Anderson C, Jones D, Aebig J, Brockley S, MacDonald NJ, Wang X, Fay MP, Healy SA, Durbin AP, Narum DL, Wu Y, Duffy PE.

PLoS One. 2016 Oct 17;11(10):e0163144. doi: 10.1371/journal.pone.0163144. eCollection 2016.

Supplemental Content

Loading ...
Support Center